Creating Biomedical Technologies to Improve Health



Grantee News • October 30, 2012

A team of researchers including NIBIB investigator Kit Lam at the University of California Davis has discovered a new class of nanoparticles capable of packaging a diverse array of drugs. Research findings demonstrate structural and dynamic changes within nanoparticles during interaction with blood proteins which will result in better designed nanomedicines that will be therapeutically more efficacious. Read the full article from ACSNano.

Press Releases • October 15, 2012
The National Institutes of Health plans to invest more than $90 million over five years, contingent upon the availability of funds, to accelerate the development and application of single cell analysis across a variety of fields. The goal is to understand what makes individual cells unique and to pave the way for medical treatments that are based on disease mechanisms at the cellular level.
Grantee News • October 12, 2012

Led by a grant from the National Science Foundation (NSF), Mark Chance, PhD, director of the Center for Proteomics and Bioinformatics at Case Western Reserve University School of Medicine, has been awarded $4 million for work with the National Synchrotron Light Source II (NSLS II) at Brookhaven National Laboratory in New York. Read the full news release from Medicus.

NIBIB in the News • October 1, 2012
Hari Shroff, Chief, Section on High Resolution Optical Imaging at NIBIB was one of four microscopy innovators/researchers asked to discuss novel approaches in his lab. Shroff works on high-resolution imaging of zebrafish embryonic development. Since super high resolution microscopy techniques typically cannot be applied to live samples because they are both slow and relatively toxic to the cells, he has built a system that couples the super-resolution of Structured Illumination Imaging (SIM) and confocal microscopy–a technique that allows him to image samples several cell layers deep. Read the full article from The Scientist.
Grantee News • September 24, 2012

Dr. Joachim Kohn, AFIRM's Director and an NIBIB Principal Investigator, takes people ravaged by war and helps discover new ways to put them (literally) back together through tissue engineering, renerative processes like bone and nerve repair, face transplants, human transplantation, and an engineered skin substitute for burns. Read the full article from

Press Releases • September 17, 2012
Six projects have been awarded funding to develop robots that can interact and work cooperatively with people and respond to changing environments in a variety of healthcare applications, the National Institutes of Health, collaborating with three other federal agencies, announced last week. The total amount for these projects over the next four years amounts to $4.4M, subject to the availability of funds.
NIBIB in the News • September 12, 2012
Howard Hughes Medical Institute announces funding of graduate biomedical training awards in collaboration with NIBIB. William Heetderks comments on importance of training for biomedical researchers and NIBIB-HHMI collaboration. Read the full article from the Howard Hughes Medical Institute.
Grantee News • September 4, 2012

A new study by University of Kentucky researchers, carried out in the laboratory of Pexiuan Guo, an NIBIB PI, shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. Read the full article from University of Kentucky.

Grantee News • September 4, 2012

Point-of-care tests for chlamydia as developed by NIBIB-funded researcher Charlotte Gaydos are more cost-effective than traditional nucleic acid amplification test (NAAT) in a clinic when specified characteristics (sensitivity, specificity, cost, and willingness to wait in a clinic for POC test results) are met. Read the full article from Johns Hopkins.

Science Highlights • August 30, 2012
How much radiation in medical tests is too much? NIBIB is taking a central role on an initiative to develop new methods and technologies for reducing the radiation dose from routine CT scans while maintaining the high quality of the images produced.